Cosmos Health Inc. (COSM) Stock Analysis & Investment Frameworks
Cosmos Health Inc. (COSM) stock analysis on Invetso. Review Cosmos Health Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Cosmos Health Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Pharmaceuticals
- Country: GR
Cosmos Health Inc. Key Financial Metrics
- Market Cap: $29.17M
- Revenue: $65.27M
- ROE: -118.89%
- ROIC: -46.45%
- Dividend Yield: N/A
About Cosmos Health Inc.
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Cosmos Health Inc. Investment Frameworks
Invetso analyzes Cosmos Health Inc. (COSM) across the following frameworks:
- Cosmos Health Inc. 10Y Growth Potential
- Cosmos Health Inc. Scenario Analysis
- Cosmos Health Inc. Risks & Opportunities
- Cosmos Health Inc. Economic Moat
- Cosmos Health Inc. Business Model
- Cosmos Health Inc. Management
- Cosmos Health Inc. SWOT Analysis
- Cosmos Health Inc. Porter's 5 Forces
- Cosmos Health Inc. PESTLE Analysis
- Cosmos Health Inc. ESG Analysis